Hcw Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.40

+0.03 (+6.92%)

As of Mar 29, 11:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,833.6% upside

Low Target $12.72

Average Target $19.68

High Target $25.92

Current Price $0.40

Current
$0.40

Target
$19.68

$12.72 $19.68 avg $25.92

Scenario Analysis

Bear Case

$12.72

3,088.8%

Low target

Base Case

$19.68

+4,833.6%

Avg target

Bull Case

$25.92

+6,397.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$17.80

-97.8% from high

52-Week Low

$0.36

+11.2% from low

Target vs 52W High

$19.68

+10.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%